In December 2020, Utah’s Newborn Screening Program identified the first patient with Guanidinoacetate methyltransferase (GAMT) deficiency solely through newborn screening. GAMT deficiency is an inherited condition that affects the body’s...
Highlighting investigators and their pioneering research programs, the Vitae program seeds new collaborations and development strategies by humanizing research through story.
Massive "plumes" of a key neurotransmitter surging in the brain could help explain the onset of migraine with aura—and potentially a broad swath of neurologic disease, including stroke and traumatic...
Sobering new statistics released by the Global Burden of Disease study found no significant reduction in the number of people with treatable sight loss worldwide since 2010 as public health...
Yves Lussier, MD, FACMI, has been named Chair of Biomedical Informatics at University of Utah School of Medicine. The appointment, effective February 1, 2021, was announced by Michael L. Good...
Mark H. Rapaport, M.D., a nationally recognized clinician and researcher known for his interdisciplinary approach to mental health treatment and care, has been named CEO of Huntsman Mental Health Institute...
The Center for Medical Innovation (CMI) at the University of Utah announced plans this week to expand its operations to the University of Utah Asia Campus (UAC) on the Incheon...
As positive COVID-19 cases in Utah set record highs, two of the nation’s top health officials visited the University of Utah today for an informal discussion on the pandemic. Deborah...
In a new multicenter study, researchers led by University of Utah surgeons report that an emerging heart failure treatment could potentially reverse structural damage to the heart, allowing it to...